# LAM Research Corp: financial statements, quarterly

LRCX · Nasdaq · CIK 707549 · [Industrials](/sectors/industrials.md) · fiscal year ends Jun 27

Pages: [Overview](/companies/lrcx.md) · [Financials](/companies/lrcx/financials.md) · [Filings](/companies/lrcx/filings.md) · [Insiders](/companies/lrcx/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/lrcx/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2024 (2023-12-24) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-29) | Q2 FY2025 (2024-12-29) | Q3 FY2025 (2025-03-30) | Q4 FY2025 (2025-06-29) | Q1 FY2026 (2025-09-28) | Q2 FY2026 (2025-12-28) | Q3 FY2026 (2026-03-29) | Q4 FY2026 (2026-06-28) | Q1 FY2027 (2026-09-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [3,758](/filings/0000707549-25-000014.md) | [3,794](/filings/0000707549-25-000054.md) | [3,872 d](/filings/0000707549-26-000037.md) | [4,168](/filings/0000707549-25-000085.md) | [4,376](/filings/0000707549-26-000009.md) | [4,720](/filings/0000707549-26-000022.md) | [5,171 d](/filings/0000707549-26-000037.md) | [5,324](/filings/0000707549-26-000054.md) | [5,345](/filings/0000707549-26-000009.md) | [5,841](/filings/0000707549-26-000022.md) | [6,722 d](/filings/0000707549-26-000037.md) | [8,219](/filings/0000707549-26-000054.md) |
| Cost of revenue | $m | [2,001](/filings/0000707549-25-000014.md) | [1,993](/filings/0000707549-25-000054.md) | [2,031 d](/filings/0000707549-26-000037.md) | [2,165](/filings/0000707549-24-000128.md) | [2,303](/filings/0000707549-25-000014.md) | [2,406](/filings/0000707549-25-000054.md) | [2,582 d](/filings/0000707549-26-000037.md) | not reported | not reported | not reported | not reported | not reported |
| Gross profit | $m | [1,757](/filings/0000707549-25-000014.md) | [1,801](/filings/0000707549-25-000054.md) | [1,840 d](/filings/0000707549-26-000037.md) | [2,003](/filings/0000707549-25-000085.md) | [2,073](/filings/0000707549-26-000009.md) | [2,314](/filings/0000707549-26-000022.md) | [2,590 d](/filings/0000707549-26-000037.md) | [2,685](/filings/0000707549-26-000054.md) | [2,651](/filings/0000707549-26-000009.md) | [2,911](/filings/0000707549-26-000022.md) | [3,479 d](/filings/0000707549-26-000037.md) | [4,299](/filings/0000707549-26-000054.md) |
| Research and development | $m | [470](/filings/0000707549-25-000014.md) | [512](/filings/0000707549-25-000054.md) | [498 d](/filings/0000707549-26-000037.md) | [495](/filings/0000707549-25-000085.md) | [495](/filings/0000707549-26-000009.md) | [526](/filings/0000707549-26-000022.md) | [580 d](/filings/0000707549-26-000037.md) | [576](/filings/0000707549-26-000054.md) | [573](/filings/0000707549-26-000009.md) | [583](/filings/0000707549-26-000022.md) | [643 d](/filings/0000707549-26-000037.md) | [666](/filings/0000707549-26-000054.md) |
| Selling, general and administrative | $m | [229](/filings/0000707549-25-000014.md) | [216](/filings/0000707549-25-000054.md) | [216 d](/filings/0000707549-26-000037.md) | [243](/filings/0000707549-25-000085.md) | [244](/filings/0000707549-26-000009.md) | [226](/filings/0000707549-26-000022.md) | [268 d](/filings/0000707549-26-000037.md) | [279](/filings/0000707549-26-000054.md) | [268](/filings/0000707549-26-000009.md) | [280](/filings/0000707549-26-000022.md) | [322 d](/filings/0000707549-26-000037.md) | [349](/filings/0000707549-26-000054.md) |
| Operating income | $m | [1,057](/filings/0000707549-25-000014.md) | [1,057](/filings/0000707549-25-000054.md) | [1,127 d](/filings/0000707549-26-000037.md) | [1,264](/filings/0000707549-25-000085.md) | [1,334](/filings/0000707549-26-000009.md) | [1,562](/filings/0000707549-26-000022.md) | [1,741 d](/filings/0000707549-26-000037.md) | [1,829](/filings/0000707549-26-000054.md) | [1,810](/filings/0000707549-26-000009.md) | [2,047](/filings/0000707549-26-000022.md) | [2,513 d](/filings/0000707549-26-000037.md) | [3,284](/filings/0000707549-26-000054.md) |
| Interest expense | $m | [46.3](/filings/0000707549-24-000016.md) | [47.2](/filings/0000707549-24-000067.md) | [46.4 d](/filings/0000707549-26-000037.md) | [44.9](/filings/0000707549-25-000085.md) | [45.3](/filings/0000707549-26-000009.md) | [45.2](/filings/0000707549-26-000022.md) | [42.8 d](/filings/0000707549-26-000037.md) | [42.5](/filings/0000707549-26-000054.md) | [40.9](/filings/0000707549-26-000009.md) | [39.3](/filings/0000707549-26-000022.md) | [34.2 d](/filings/0000707549-26-000037.md) | [36.8](/filings/0000707549-26-000054.md) |
| Income tax | $m | [133](/filings/0000707549-25-000014.md) | [127](/filings/0000707549-25-000054.md) | [134 d](/filings/0000707549-26-000037.md) | [178](/filings/0000707549-25-000085.md) | [157](/filings/0000707549-26-000009.md) | [206](/filings/0000707549-26-000022.md) | [58.9 d](/filings/0000707549-26-000037.md) | [291](/filings/0000707549-26-000054.md) | [243](/filings/0000707549-26-000009.md) | [186](/filings/0000707549-26-000022.md) | [278 d](/filings/0000707549-26-000037.md) | [559](/filings/0000707549-26-000054.md) |
| Net income | $m | [954](/filings/0000707549-25-000014.md) | [966](/filings/0000707549-25-000054.md) | [1,020 d](/filings/0000707549-26-000037.md) | [1,116](/filings/0000707549-25-000085.md) | [1,191](/filings/0000707549-26-000009.md) | [1,331](/filings/0000707549-26-000022.md) | [1,720 d](/filings/0000707549-26-000037.md) | [1,569](/filings/0000707549-26-000054.md) | [1,594](/filings/0000707549-26-000009.md) | [1,825](/filings/0000707549-26-000022.md) | [2,277 d](/filings/0000707549-26-000037.md) | [2,753](/filings/0000707549-26-000054.md) |
| Diluted EPS | $ per share | [0.72](/filings/0000707549-25-000014.md) | [0.73](/filings/0000707549-25-000054.md) | not reported | [0.86](/filings/0000707549-25-000085.md) | [0.92](/filings/0000707549-26-000009.md) | [1.03](/filings/0000707549-26-000022.md) | not reported | [1.24](/filings/0000707549-26-000054.md) | [1.26](/filings/0000707549-26-000009.md) | [1.45](/filings/0000707549-26-000022.md) | not reported | [2.19](/filings/0000707549-26-000054.md) |
| Basic EPS | $ per share | [0.72](/filings/0000707549-25-000014.md) | [0.74](/filings/0000707549-25-000054.md) | not reported | [0.86](/filings/0000707549-25-000085.md) | [0.93](/filings/0000707549-26-000009.md) | [1.04](/filings/0000707549-26-000022.md) | not reported | [1.24](/filings/0000707549-26-000054.md) | [1.27](/filings/0000707549-26-000009.md) | [1.46](/filings/0000707549-26-000022.md) | not reported | [2.20](/filings/0000707549-26-000054.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2024 (2023-12-24) | Q3 FY2024 (2024-03-31) | FY2024 (2024-06-30) | Q1 FY2025 (2024-09-29) | Q2 FY2025 (2024-12-29) | Q3 FY2025 (2025-03-30) | FY2025 (2025-06-29) | Q1 FY2026 (2025-09-28) | Q2 FY2026 (2025-12-28) | Q3 FY2026 (2026-03-29) | FY2026 (2026-06-28) | Q1 FY2027 (2026-09-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [5.6](/filings/0000707549-25-000014.md) | [5.7](/filings/0000707549-25-000054.md) | [5.8](/filings/0000707549-26-000037.md) | [6.1](/filings/0000707549-25-000085.md) | [5.7](/filings/0000707549-26-000009.md) | [5.5](/filings/0000707549-26-000022.md) | [6.4](/filings/0000707549-26-000037.md) | [6.7](/filings/0000707549-26-000054.md) | [6.2](/filings/0000707549-26-000009.md) | [4.8](/filings/0000707549-26-000022.md) | [5.6](/filings/0000707549-26-000054.md) | [7.4](/filings/0000707549-26-000054.md) |
| Current assets | $bn | [13.1](/filings/0000707549-24-000016.md) | [12.5](/filings/0000707549-24-000067.md) | [12.9](/filings/0000707549-25-000075.md) | [13.5](/filings/0000707549-24-000128.md) | [13.6](/filings/0000707549-25-000014.md) | [13.5](/filings/0000707549-25-000054.md) | [14.5](/filings/0000707549-26-000037.md) | [14.8](/filings/0000707549-25-000085.md) | [14.0](/filings/0000707549-26-000009.md) | [13.3](/filings/0000707549-26-000022.md) | [15.6](/filings/0000707549-26-000054.md) | [18.1](/filings/0000707549-26-000054.md) |
| Total assets | $bn | [18.8](/filings/0000707549-24-000016.md) | [18.3](/filings/0000707549-24-000067.md) | [18.7](/filings/0000707549-25-000075.md) | [19.5](/filings/0000707549-24-000128.md) | [19.8](/filings/0000707549-25-000014.md) | [20.0](/filings/0000707549-25-000054.md) | [21.3](/filings/0000707549-26-000037.md) | [21.9](/filings/0000707549-25-000085.md) | [21.4](/filings/0000707549-26-000009.md) | [20.8](/filings/0000707549-26-000022.md) | [23.5](/filings/0000707549-26-000054.md) | [26.4](/filings/0000707549-26-000054.md) |
| Current liabilities | $bn | [4.3](/filings/0000707549-24-000016.md) | [4.4](/filings/0000707549-24-000067.md) | [4.3](/filings/0000707549-25-000075.md) | [5.3](/filings/0000707549-24-000128.md) | [5.4](/filings/0000707549-25-000014.md) | [5.5](/filings/0000707549-25-000054.md) | [6.6](/filings/0000707549-26-000037.md) | [6.7](/filings/0000707549-25-000085.md) | [6.2](/filings/0000707549-26-000009.md) | [5.2](/filings/0000707549-26-000022.md) | [5.9](/filings/0000707549-26-000054.md) | [7.3](/filings/0000707549-26-000054.md) |
| Total liabilities | $bn | [10.6](/filings/0000707549-24-000016.md) | [10.3](/filings/0000707549-24-000067.md) | [10.2](/filings/0000707549-25-000075.md) | [11.1](/filings/0000707549-24-000128.md) | [11.0](/filings/0000707549-25-000014.md) | [10.5](/filings/0000707549-25-000054.md) | [11.5](/filings/0000707549-26-000037.md) | [11.7](/filings/0000707549-25-000085.md) | [11.2](/filings/0000707549-26-000009.md) | [10.2](/filings/0000707549-26-000022.md) | [11.1](/filings/0000707549-26-000054.md) | [12.4](/filings/0000707549-26-000054.md) |
| Long-term debt | $bn | not reported | not reported | [4.5](/filings/0000707549-25-000075.md) | not reported | not reported | not reported | [3.7](/filings/0000707549-26-000037.md) | not reported | not reported | not reported | [3.7](/filings/0000707549-26-000037.md) | not reported |
| Current portion of debt | $bn | not reported | not reported | [0.5](/filings/0000707549-25-000075.md) | not reported | not reported | not reported | [0.7](/filings/0000707549-26-000037.md) | not reported | not reported | not reported | [0.0](/filings/0000707549-26-000037.md) | not reported |
| Shareholders' equity | $bn | [8.2](/filings/0000707549-25-000054.md) | [8.0](/filings/0000707549-25-000054.md) | [8.5](/filings/0000707549-26-000037.md) | [8.5](/filings/0000707549-26-000009.md) | [8.8](/filings/0000707549-26-000022.md) | [9.5](/filings/0000707549-26-000022.md) | [9.9](/filings/0000707549-26-000054.md) | [10.2](/filings/0000707549-26-000054.md) | [10.1](/filings/0000707549-26-000022.md) | [10.6](/filings/0000707549-26-000022.md) | [12.5](/filings/0000707549-26-000054.md) | [13.9](/filings/0000707549-26-000054.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2024 (2023-12-24) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-29) | Q2 FY2025 (2024-12-29) | Q3 FY2025 (2025-03-30) | Q4 FY2025 (2025-06-29) | Q1 FY2026 (2025-09-28) | Q2 FY2026 (2025-12-28) | Q3 FY2026 (2026-03-29) | Q4 FY2026 (2026-06-28) | Q1 FY2027 (2026-09-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [1,454 d](/filings/0000707549-25-000014.md) | [1,385 d](/filings/0000707549-25-000054.md) | [862 d](/filings/0000707549-26-000037.md) | [1,568](/filings/0000707549-25-000085.md) | [742 d](/filings/0000707549-26-000009.md) | [1,309 d](/filings/0000707549-26-000022.md) | [2,554 d](/filings/0000707549-26-000037.md) | [1,779](/filings/0000707549-26-000054.md) | [1,480 d](/filings/0000707549-26-000009.md) | [1,141 d](/filings/0000707549-26-000022.md) | [1,457 d](/filings/0000707549-26-000037.md) | [3,498](/filings/0000707549-26-000054.md) |
| Capital expenditure | $m | [115 d](/filings/0000707549-25-000014.md) | [104 d](/filings/0000707549-25-000054.md) | [101 d](/filings/0000707549-26-000037.md) | [111](/filings/0000707549-25-000085.md) | [188 d](/filings/0000707549-26-000009.md) | [288 d](/filings/0000707549-26-000022.md) | [172 d](/filings/0000707549-26-000037.md) | [185](/filings/0000707549-26-000054.md) | [261 d](/filings/0000707549-26-000009.md) | [332 d](/filings/0000707549-26-000022.md) | [189 d](/filings/0000707549-26-000037.md) | [258](/filings/0000707549-26-000054.md) |
| Dividends paid | $m | [264 d](/filings/0000707549-25-000014.md) | [263 d](/filings/0000707549-25-000054.md) | [261 d](/filings/0000707549-26-000037.md) | [261](/filings/0000707549-25-000085.md) | [298 d](/filings/0000707549-26-000009.md) | [296 d](/filings/0000707549-26-000022.md) | [295 d](/filings/0000707549-26-000037.md) | [292](/filings/0000707549-26-000054.md) | [328 d](/filings/0000707549-26-000009.md) | [326 d](/filings/0000707549-26-000022.md) | [325 d](/filings/0000707549-26-000037.md) | [325](/filings/0000707549-26-000054.md) |
| Share repurchases | $m | [645 d](/filings/0000707549-25-000014.md) | [981 d](/filings/0000707549-25-000054.md) | [374 d](/filings/0000707549-26-000037.md) | [997](/filings/0000707549-25-000085.md) | [698 d](/filings/0000707549-26-000009.md) | [435 d](/filings/0000707549-26-000022.md) | [1,292 d](/filings/0000707549-26-000037.md) | [976](/filings/0000707549-26-000054.md) | [1,466 d](/filings/0000707549-26-000009.md) | [1,163 d](/filings/0000707549-26-000022.md) | [247 d](/filings/0000707549-26-000037.md) | [1,025](/filings/0000707549-26-000054.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q2 FY2023 (2022-12-25) | Q3 FY2023 (2023-03-26) | Q1 FY2024 (2023-09-24) | Q2 FY2024 (2023-12-24) | Q3 FY2024 (2024-03-31) | Q1 FY2025 (2024-09-29) | Q2 FY2025 (2024-12-29) | Q3 FY2025 (2025-03-30) | Q1 FY2026 (2025-09-28) | Q2 FY2026 (2025-12-28) | Q3 FY2026 (2026-03-29) | Q1 FY2027 (2026-09-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [136](/filings/0000707549-24-000016.md) | [135](/filings/0000707549-24-000067.md) | [1,332](/filings/0000707549-24-000128.md) | [1,322](/filings/0000707549-25-000014.md) | [1,315](/filings/0000707549-25-000054.md) | [1,304](/filings/0000707549-25-000085.md) | [1,291](/filings/0000707549-26-000009.md) | [1,288](/filings/0000707549-26-000022.md) | [1,269](/filings/0000707549-26-000054.md) | [1,262](/filings/0000707549-26-000009.md) | [1,257](/filings/0000707549-26-000022.md) | [1,256](/filings/0000707549-26-000054.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 1,249,171,000 at 2026-10-20, from the cover of the [10-Q filed 2026-10-22](/filings/0000707549-26-000054.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:22 ET. No prices; not investment advice.